Moderna reports COVID-19 vaccine works well in children
Moderna said that it will submit a request for authorization of a 25 μg two-dose primary series of mRNA-1273 for children aged 6 months old to under 6 years old to the FDA, EMA and other global regulators in the coming weeks.